← Leaderboards
Irene Munk Pedersen
University Of California, San Diego
$5,110,970
Attributed
$8,107,492
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,107,492 · 6
By mechanism
R61$2,939,353 · 2
R01$2,411,803 · 2
R33$2,181,059 · 1
K01$575,277 · 1
Top collaborators
- Dritan Agalliu7 shared
- Raphael Lis6 shared
- Marcus Kaul1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Richard Daneman$10,366,847
- Elina I Zuniga$19,346,848
- Carol H Yan$767,492
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmuneBlood - Brain Barrier AnatomyBloodBrainInduced Pluripotent Stem CellPericytesT-LymphocyteBlood VesselsFunctional DisorderInjurySignal TransductionBrain InjuriesAstrocytesPathogenesisThree-Dimensional ModelingViralBrain Endothelial CellPropertySeveritiesProteinsDisabilityMediatingPeripheral
Grant awards (18)
Intersection of Neuro-Immune-Vascular Dynamics in Preclinical NeuroHIV Model$1,025,015
R61 · FY2025 · NS · contact PI
Harnessing Innate Immunity to Control the Neuroinflammatory HIV Reservoir$698,390
R01 · FY2025 · NS
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$577,505
R33 · FY2025 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$540,496
R33 · FY2024 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$497,625
R33 · FY2024 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$565,433
R33 · FY2023 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$944,440
R61 · FY2022 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using avascularized and perfused human blood/BBB model.$17,898
R61 · FY2022 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$952,000
R61 · FY2021 · HL
miR regulation of the neurovasculature function in health and disease$472,986
R01 · FY2021 · NS · contact PI
miR regulation of the neurovasculature function in health and disease$474,759
R01 · FY2020 · NS · contact PI
miR regulation of the neurovasculature function in health and disease$381,596
R01 · FY2019 · NS · contact PI
miR regulation of the neurovasculature function in health and disease$384,072
R01 · FY2018 · NS · contact PI
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells$137,220
K01 · FY2011 · CA · contact PI
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells$113,196
K01 · FY2010 · CA · contact PI
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells$110,843
K01 · FY2009 · CA · contact PI
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells$108,558
K01 · FY2008 · CA · contact PI
Cooperation of PTEN and SHIP as tumor suppressors in B-Cells$105,460
K01 · FY2007 · CA · contact PI